A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25042409 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alexandra E Butler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Royal College of Surgeons of Ireland, Busaiteen P.O. Box 15503, Bahrain. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Diabetes Mellitus, Type 2, Dementia, Insulin Resistance. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Dysregulated Alzheimer’s disease (AD)-associated protein expression is reported in polycystic ovary syndrome (PCOS), paralleling the expression reported in type 2 diabetes (T2D). We hypothesized, however, that these proteins would not differ between women with non-obese and non-insulin resistant PCOS compared to matched control subjects. We measured plasma amyloid-related proteins levels (Amyloid-precursor protein (APP), alpha-synuclein (SNCA), amyloid P-component (APCS), Pappalysin (PAPPA), Microtubule-associated protein tau (MAPT), apolipoprotein E (apoE), apoE2, apoE3, apoE4, Serum amyloid A (SAA), Noggin (NOG) and apoA1) in weight and aged-matched non-obese PCOS (n = 24) and control (n = 24) women. Dementia-related proteins fibronectin (FN), FN1.3, FN1.4, Von Willebrand factor (VWF) and extracellular matrix protein 1 (ECM1) were also measured. Protein levels were determined by Slow Off-rate Modified Aptamer (SOMA)-scan plasma protein measurement. Only APCS differed between groups, being elevated in non-obese PCOS women (p = 0.03) relative to the non-obese control women. This differed markedly from the elevated APP, APCS, ApoE, FN, FN1.3, FN1.4 and VWF reported in obese women with PCOS. Non-obese, non-insulin resistant PCOS subjects have a lower AD-associated protein pattern risk profile versus obese insulin resistant PCOS women, and are not dissimilar to non-obese controls, indicating that lifestyle management to maintain optimal body weight could be beneficial to reduce the long-term AD-risk in women with PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Department, Royal College of Surgeons of Ireland, Busaiteen P.O. Box 15503, Bahrain.
- Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RU, UK.
ORCID-Profile: Alexandra E Butler, Thozhukat Sathyapalan, Stephen L Atkin
Zitieren
APA
Butler, A. E., Moin, A. S. M., Sathyapalan, T., & Atkin, S. L. (2024). A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042409
Vancouver
Butler AE, Moin ASM, Sathyapalan T, Atkin SL. A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042409
BibTeX
@article{Butler2024,
author = {Butler, Alexandra E and Moin, Abu Saleh Md and Sathyapalan, Thozhukat and Atkin, Stephen L},
title = {A Cross-Sectional Study of Protein Changes Associated with Dementia in Non-Obese Weight Matched Women with and without Polycystic Ovary Syndrome},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25042409}
}
EUVIMED